Multiple myeloma.
Samson
D
D
Imperial College, London.
Singer
C
C
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003937:Diagnosis, Differential; D018450:Disease Progression; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D023461:Myeloid Progenitor Cells / Q000502:physiology; D009367:Neoplasm Staging; D010265:Paraproteinemias / Q000503:physiopathology; D011379:Prognosis; D017154:Stromal Cells / Q000502:physiology; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D018906:Antineoplastic Agents, Alkylating; D016898:Interferon-alpha; D014409:Tumor Necrosis Factor-alpha